[Antitumor effect of bacterial lipopolysaccharide (LPS) and a combination use of LPS and lentinan on C3H/He mice bearing MH-134 tumor]. 1983

N Moriya, and H Miwa, and S Taketsuka, and K Orita

Using C3H/He mice a series of experiments was carried to study the antitumor effect of lipopolysaccharide (LPS) in combined use with Lentinan extracted from Cortinellus shiitake and its influence on cellular immunity as well as antitumor effect of tumor necrosis factor (TNF) prepared from LPS, and the following results were obtained: 1) In the cases where LPS was administered when the tumor had grown to a certain extent after tumor transplantation, hemorrhagic necrosis of the tumor occurred within 48 hours, showing a high antitumor effect. 2) In the cases where LPS was used with Lentinan, i.e., 2 mg/kg/day of Lentinan was administered from the 1st to the 8th day after tumor transplantation, and 30 micrograms/kg of LPS given on the 12th day, the highest antitumor effect could be achieved. 3) By combined use of LPS and Lentinan delayed type hypersensitivity was intensified. 4) Upon application of rabbit serum containing TNF to cancer bearing mice, hemorrhagic necrosis of the tumor was observed within 48 hours, and a superior antitumor effect compared to LPS alone was noted in terms of tumor size and weight.

UI MeSH Term Description Entries
D007912 Lentinan Polysaccharide isolated from the edible mushroom LENTINULA EDODES. The exact composition is unknown.
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D011134 Polysaccharides Long chain polymeric CARBOHYDRATES composed of MONOSACCHARIDES linked by glycosidic bonds. Glycan,Glycans,Polysaccharide
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females

Related Publications

N Moriya, and H Miwa, and S Taketsuka, and K Orita
February 1982, Acta medica Okayama,
N Moriya, and H Miwa, and S Taketsuka, and K Orita
July 1982, Gan to kagaku ryoho. Cancer & chemotherapy,
N Moriya, and H Miwa, and S Taketsuka, and K Orita
February 1979, The Tohoku journal of experimental medicine,
N Moriya, and H Miwa, and S Taketsuka, and K Orita
June 1969, The Japanese journal of experimental medicine,
N Moriya, and H Miwa, and S Taketsuka, and K Orita
February 1982, Gan,
N Moriya, and H Miwa, and S Taketsuka, and K Orita
February 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
N Moriya, and H Miwa, and S Taketsuka, and K Orita
April 1997, Anti-cancer drugs,
N Moriya, and H Miwa, and S Taketsuka, and K Orita
December 1986, The Tohoku journal of experimental medicine,
N Moriya, and H Miwa, and S Taketsuka, and K Orita
November 2006, Gan to kagaku ryoho. Cancer & chemotherapy,
N Moriya, and H Miwa, and S Taketsuka, and K Orita
August 1983, European journal of cancer & clinical oncology,
Copied contents to your clipboard!